PD-1 binding to PD-L1 specifically inhibits T-cell activation and represents one mechanism of immune tumour escape.6 TNBCs are thought to be more immunogenic than other BC and AR + TNBC show a higher frequency of PD-L1 expression.7 This evidence concerns the gene AR and neoplasm.